The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure ...

Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their ...

Manufacturers have been asked to adopt risk-based approaches, including stricter testing protocols, revised storage ...

NDMA is classified as a Group 2A carcinogen by the International Agency for Research on Cancer (IARC), indicating it is a ...

An announcement from Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) is now available. On July 25, 2025, Incannex Healthcare Inc. announced ...

The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a ...

Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a potentially carcinogenic chemical — ...

Internationally recognised life science leaders are set to provide expert technical guidance to support Cambridge-based ...

CDSCO is monitoring ranitidine due to NDMA, a potential carcinogen. The DTAB recommended a study on the drug's safety, ...

New Delhi: The health ministry is set to deregulate the sale of common household liquid antiseptics, with a new policy in the ...

LUB raises various concerns and demands related to pharma industry: Our Bureau, New Delhi Saturday, July 19, 2025, 08:00 Hrs [IST] Laghu Udyog Bharati (LUB), the association repre ...